Press release
Glioblastoma Market Size in the 7MM is approximately USD XX Million in 2023, estimates DelveInsight
"The Glioblastoma market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period (2023-2034). Furthermore, launching various multiple- Glioblastoma pipeline products will significantly revolutionize the Glioblastoma market dynamics"The Glioblastoma market report provides current treatment practices, Glioblastoma emerging drugs, market share of individual therapies, and current and forecasted 7MM Glioblastoma market size from 2020 to 2034. The report also covers current Glioblastoma treatment market practices/algorithms and unmet medical needs to curate the best opportunities and assess the market's underlying potential.
Key Takeaways from the Glioblastoma Market Research Report
• The total Glioblastoma Market Size in the United States is expected to increase with a CAGR of XX% during the study period (2020-2034).
• The leading companies working in the Glioblastoma Market include VBL Therapeutics, Diffusion Pharmaceuticals, Bayer, MedImmune, DNAtrix, Oncoceutics, Karyopharm Therapeutics, VBI Vaccines, Kazia Therapeutics, Aivita Biomedical, Medicenna Therapeutics, Kintara Therapeutics, Immunomic Therapeutics, Inovio Pharmaceuticals, and others.
• Promising Glioblastoma Pipeline Therapies in the various stages of development includes PLX3397, Temozolomide, VXM01, Cilengitide, ACT001, LAM561, TMZ, Onfekafusp alfa, and others.
• September 2023: Cantex Pharmaceuticals announced a study of phase 1 & 2 clinical trials for Azeliragon 5 mg. This is an open label study to determine the safety and preliminary evidence of a therapeutic effect of azeliragon in patients with newly diagnosed glioblastoma receiving concurrent radiation and temozolomide.
• September 2023: In8bio Inc. announced a study of phase 1 & 2 clinical trials for Autologous genetically modified gamma-delta T cells. This multicenter, Phase 1b/2 study is being conducted to determine if the experimental cell therapy is safe, tolerable and can delay the return of cancer in patients with a newly diagnosed or recurrent glioblastoma multiforme (GBM) in combination with standard chemotherapy treatment temozolomide (TMZ). If there is a 25% or greater improvement in survival in this study then the therapy should be studied further.
Discover more about therapies set to grab major Glioblastoma Market Share @ Glioblastoma Market Size- https://www.delveinsight.com/report-store/glioblastoma-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Glioblastoma Overview
A cancerous development of cells in the brain or spinal cord is the precursor to Glioblastoma. It can penetrate healthy tissue and wreak havoc there as it grows swiftly. The astrocytes that support nerve cells are the source of Glioblastoma development. Anyone can develop Glioblastoma at any age.
Glioblastoma Epidemiology Segmentation in the 7MM
• Total Glioblastoma Diagnosed Incident Population
• Glioblastoma Gender-specific Diagnosed Incidence
• Glioblastoma Type-specific Diagnosed Incidence
• Glioblastoma Age-specific Diagnosed Incidence
• Glioblastoma Diagnosed Incident Population based on Primary Site
• Glioblastoma Diagnosed Incident Population based on Histologic Classification
Download the report to understand which factors are driving Glioblastoma Epidemiology Trends @ Glioblastoma Epidemiological Insights- https://www.delveinsight.com/sample-request/glioblastoma-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Glioblastoma Treatment Market
The Glioblastoma Treatment Market, a pivotal segment of the healthcare industry, encompasses the diverse array of therapies, drugs, and interventions designed to combat Glioblastoma, an aggressive and often fatal form of brain cancer. Glioblastoma Multiforme (GBM) is notorious for its resistance to conventional treatments, making research and development in this field crucial.
Glioblastoma Market Outlook
Glioblastoma treatment is quite challenging as some cells may respond well to certain therapies, while others may not be affected at all. Because of this, the treatment plan for glioblastoma may combine several approaches. The treatment often comprises a combination of several therapies, including surgery, chemotherapy, radiation, or stereotactic radiosurgery followed by the additional/adjuvant treatments, such as chemotherapy or radiation therapy, after surgery.
To know more about Glioblastoma Treatment options, visit @ Glioblastoma Drugs- https://www.delveinsight.com/sample-request/glioblastoma-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Glioblastoma Marketed Drugs
• Avastin: Genentech
• Temodar/Temodal: Merck
Glioblastoma Emerging Drugs
• Ofranergene obadenovec (VB-111): VBL Therapeutics
• Trans Sodium Crocetinate: Diffusion Pharmaceuticals
• Selinexor (KPT-330): Karyopharm Therapeutics
• VBI-1901: VBI Vaccines
• ITI-1000 (pp65 DC Vaccine): Immunomic Therapeutics
Learn more about the Glioblastoma Pipeline Therapies in clinical trials @ Glioblastoma Market Landscape- https://www.delveinsight.com/sample-request/glioblastoma-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Scope of the Glioblastoma Market Research Report
• Coverage- 7MM
• Glioblastoma Companies- VBL Therapeutics, Diffusion Pharmaceuticals, Bayer, MedImmune, DNAtrix, Oncoceutics, Karyopharm Therapeutics, VBI Vaccines, Kazia Therapeutics, Aivita Biomedical, Medicenna Therapeutics, Kintara Therapeutics, Immunomic Therapeutics, Inovio Pharmaceuticals, and others.
• Glioblastoma Pipeline Therapies- PLX3397, Temozolomide, VXM01, Cilengitide, ACT001, LAM561, TMZ, Onfekafusp alfa, and others.
• Glioblastoma Market Dynamics: Glioblastoma Market Drivers and Barriers
• Glioblastoma Market Access and Reimbursement, Unmet Needs and Future Perspectives
Discover more about Glioblastoma Drugs in development @ Glioblastoma Ongoing Clinical Trials Analysis- https://www.delveinsight.com/sample-request/glioblastoma-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Table of Content
1. Key Insights
2. Glioblastoma Market Report Introduction
3. Glioblastoma Market Overview at a Glance
4. Glioblastoma Epidemiology and Market Forecast Methodology
5. Executive Summary of Glioblastoma Multiforme (GBM)
6. Key Events
7. SWOT Analysis
8. Disease Background and Overview: Glioblastoma Multiforme
9. Glioblastoma Treatment
10. Guidelines and Recommendations from Different Organizations
11. Epidemiology and Patient Population
12. Patient Journey
13. Key Endpoints in Glioblastoma Multiforme
14. Glioblastoma Marketed Products
16. Glioblastoma: Seven Major Market Analysis
17. Glioblastoma KOL Views
18. Glioblastoma Unmet Needs
19. Glioblastoma Market Access and Reimbursement
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
23. About DelveInsight
List of Published Links
https://dennydones99.blogtov.com/5325236/navigating-the-landscape-of-prader-willi-syndrome-market-insights-by-delveinsight
https://dennydones99.digitollblog.com/24749644/navigating-the-prader-willi-syndrome-market-landscape-a-comprehensive-insight-by-delveinsight
https://dennydones99.blazingblog.com/24932572/delving-into-the-prader-willi-syndrome-market-a-comprehensive-analysis-by-delveinsight
https://dennydones99.smblogsites.com/24863622/navigating-the-prader-willi-syndrome-market-delveinsight-s-comprehensive-analysis
https://dennydones99.weblogco.com/24903357/navigating-the-uncharted-territory-of-prader-willi-syndrome-market-with-delveinsight
https://dennydones99.blogdeazar.com/24967366/exploring-the-prader-willi-syndrome-market-a-comprehensive-analysis-by-delveinsight
https://dennydones99.eedblog.com/24928009/prader-willi-syndrome-market-set-to-grow
https://dennydones99.theisblog.com/25062607/exploring-the-landscape-of-prader-willi-syndrome-market-a-comprehensive-analysis-by-delveinsight
https://dennydones99.blog2freedom.com/24883870/prader-willi-syndrome-market-set-to-grow-by-2034
https://dennydones99.qodsblog.com/24928696/prader-willi-syndrome-market-set-to-see-steady-growth
https://dennydones99.bloggazza.com/24589045/prader-willi-syndrome-market-set-to-grow-by-2034
https://dennydones99.bloggactivo.com/24676190/unveiling-the-landscape-of-prader-willi-syndrome-market-a-delveinsight-analysis
https://dennydones99.bloggadores.com/24668309/prader-willi-syndrome-market-set-to-grow-by-2034
https://dennydones99.blogsvirals.com/24655514/unraveling-the-landscape-of-prader-willi-syndrome-market-a-comprehensive-analysis-by-delveinsight
https://younder.mn.co/posts/49357071
https://smush-please.mn.co/posts/49357207
https://services-4-you.mn.co/posts/49357309
https://illusion.mn.co/posts/49357412
https://network-230.mn.co/posts/49357542
https://dennydones99.blog2learn.com/72807556/navigating-the-prader-willi-syndrome-market-delveinsight-s-insightful-approach
https://dennydones99.blogprodesign.com/46608973/unraveling-the-prader-willi-syndrome-market-a-comprehensive-insight-by-delveinsight
https://network-79379.mn.co/members/20103624
https://ylimun.mn.co/members/20103614
http://proweb.vforums.co.uk/board/Res/topic/6864/action/view_topic/vital-sign-monitoring-devices-market
http://astarsuzuki.vforums.co.uk/general/9070/vital-sign-monitoring-devices-market
http://weareone.vforums.co.uk/general/7485/vital-sign-monitoring-devices-market
http://baigasciedil.vforums.co.uk/general/9817/vital-sign-monitoring-devices-market#9817
http://taresources.vforums.co.uk/board/general/topic/10493/action/view_topic/vital-sign-monitoring-devices-market
http://clapecasna.vforums.co.uk/general/6561/vital-sign-monitoring-devices-market
http://feiwabpagym.vforums.co.uk/general/5813/vital-sign-monitoring-devices-market
http://whatwentwrong.vforums.co.uk/general/6172/vital-sign-monitoring-devices-market-dynamics
http://freuniontest.vforums.co.uk/general/4986/vital-sign-monitoring-devices-market-segmentation
http://testforum.vforums.co.uk/board/general/topic/5292/action/view_topic/vital-sign-monitoring-devices-market-size
https://meganto-lottery.mn.co/posts/48835983
https://insurtechasia.mn.co/posts/48836158
https://yizhanverse.mn.co/posts/aids-related-kaposis-sarcoma-market-size-and-companies
https://living-word-network.mn.co/posts/48836679
https://coding-playground.mn.co/posts/48836794
https://ucat-bootcamp.mn.co/posts/48836895
https://brooklynneo.mn.co/posts/48837130
https://acatpg.mn.co/posts/48837471
https://treadmill.mn.co/posts/48838446
https://www.sengifted.org/profile/dennydones99/profile
https://soundcloud.com/dennydones
https://rotorbuilds.com/profile/30028/
https://seedly.sg/profile/denny-dones-16674a5d-069b-42d2-be15-81727ac1e4d2/
https://dj-club-sf.mn.co/posts/48906762
https://clinalleve.mn.co/posts/unveiling-the-dynamics-of-the-b-cell-chronic-lymphocytic-leukemia-market-a-delveinsight-perspective
https://expressyourcurve.mn.co/posts/48907022
https://network-4727457.mn.co/posts/48907085
https://disqus.com/channel/discusschitchatchannel/discussion/channel-discusschitchatchannel/b_cell_chronic_lymphocytic_leukemia_market_size_and_companies/
https://www.instructables.com/B-Cell-Chronic-Lymphocytic-Leukemia/
https://casper-co-coaching-and-consulting.mn.co/posts/48908283
https://community.hodinkee.com/members/dennydoness
https://dennydones99.ourcodeblog.com/24857837/exploring-the-cystic-fibrosis-market-a-comprehensive-analysis-by-delveinsight
https://dennydones99.bloggip.com/24764761/navigating-the-cystic-fibrosis-market-an-insight-into-delveinsight-s-comprehensive-analysis
https://dennydones99.creacionblog.com/24683916/navigating-the-cystic-fibrosis-market-insights-by-delveinsight
https://dennydones99.dm-blog.com/24811504/navigating-the-landscape-of-cystic-fibrosis-market-insights-by-delveinsight
https://dennydones99.tusblogos.com/24744719/unraveling-the-dynamics-of-the-cystic-fibrosis-market-a-comprehensive-analysis-by-delveinsight
https://dennydones99.spintheblog.com/25027554/exploring-the-cystic-fibrosis-market-a-comprehensive-overview-by-delveinsight
https://dennydones99.dailyblogzz.com/25113733/exploring-the-cystic-fibrosis-market-a-comprehensive-analysis-by-delveinsight
https://dennydones99.bloginder.com/25169115/exploring-the-cystic-fibrosis-market-insights-by-delveinsight
https://dennydones99.blogvivi.com/25141491/unraveling-the-landscape-of-the-cystic-fibrosis-market-a-delveinsight-analysis
https://dennydones99.bleepblogs.com/25123370/navigating-the-landscape-of-heart-failure-a-comprehensive-insight-into-the-heart-failure-market-by-delveinsight
https://dennydones99.get-blogging.com/25119287/navigating-the-landscape-of-heart-failure-a-comprehensive-insight-into-the-heart-failure-market-by-delveinsight
https://dennydones99.targetblogs.com/25139177/navigating-the-landscape-a-comprehensive-insight-into-the-heart-failure-market-by-delveinsight
https://dennydones99.newsbloger.com/25137365/navigating-the-heart-failure-market-a-comprehensive-insight-by-delveinsight
https://dennydones99.blogdal.com/25076391/navigating-the-dynamics-of-the-heart-failure-market-a-comprehensive-insight-by-delveinsight
https://dennydones99.ja-blog.com/24789080/navigating-the-heart-failure-market-a-comprehensive-insight-by-delveinsight
https://dennydones99.blogscribble.com/24826188/navigating-the-landscape-of-heart-failure-an-in-depth-exploration-of-the-heart-failure-market-by-delveinsight
https://dennydones99.madmouseblog.com/5224260/navigating-the-landscape-of-heart-failure-a-comprehensive-analysis-of-the-heart-failure-market-by-delveinsight
https://dennydones99.activoblog.com/24874978/unraveling-the-dynamics-of-the-heart-failure-market-a-comprehensive-analysis-by-delveinsight
https://dennydones99.blog-ezine.com/24836226/navigating-the-waves-of-innovation-delveinsight-s-comprehensive-analysis-of-the-heart-failure-market
https://justchatting.mn.co/posts/49275967
https://constantlycheeky.mn.co/posts/49276103
https://photography-by-michael-alan.mn.co/posts/49276184
https://friendtalk.mn.co/posts/ascites-market-insights-by-delveinsight-unraveling-the-future-landscape
https://oregon-swing-netork.mn.co/posts/ascites-market-analysis-by-delveinsight-insights-into-current-trends-and-future-prospects
https://bookmarkinglive.com/story17025445/ascites-market
https://socialmphl.com/story17964249/ascites-market
https://socialmarkz.com/story6490455/ascites-market-size
https://bookmarkstumble.com/story17725787/ascites-market-outlook
https://hindibookmark.com/story17743614/ascites-market
https://bookmark-template.com/story18308001/ascites-market-size
https://bookmark-dofollow.com/story18101398/ascites-market
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: info@delveinsight.com
Phone: 9193216187
Address: 304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Glioblastoma Market Size in the 7MM is approximately USD XX Million in 2023, estimates DelveInsight here
News-ID: 3362072 • Views: …
More Releases from DelveInsight Business Research LLP

Genital Warts Pipeline Insights Report 2025 | DelveInsight
DelveInsight's, "Genital Warts Pipeline Insight 2025" report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Genital Warts pipeline landscape. It covers the Genital Warts pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight and stay ahead…

Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
DelveInsight's "Traumatic Brain Injury Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Tthe raumatic Brain Injury pipeline landscape. It covers the Traumatic Brain Injury pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Traumatic Brain Injury pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore…

Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
DelveInsight's, "Bone Metastases Pipeline Insight, 2025," report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Bone Metastases pipeline landscape. It covers the Bone Metastasis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Bone Metastasis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight…

Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsi …
DelveInsight's "Acquired Immunodeficiency Syndrome Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Acquired Immunodeficiency Syndrome, historical and forecasted epidemiology as well as the Acquired Immunodeficiency Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
To Know in detail about the Acquired Immunodeficiency Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Acquired Immunodeficiency Syndrome Market…
More Releases for Glioblastoma
Key Trends Shaping the Future Glioblastoma Multiforme Market From 2025-2034: Adv …
Which drivers are expected to have the greatest impact on the over the glioblastoma multiforme market's growth?
The growing number of brain disorder cases is anticipated to boost the glioblastoma multiforme market in the coming years. A brain disorder is a condition that affects the brain's structure or function, leading to cognitive, emotional, or physical difficulties. The rise in brain disorder cases is attributed to factors such as an aging population,…
Glioblastoma Pipeline Outlook Report 2024 (Updated)
DelveInsight's, "Glioblastoma Pipeline Insight, 2024," report provides comprehensive insights about 195+ companies and 210+ pipeline drugs in Glioblastoma pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the Glioblastoma Pipeline Report
* DelveInsight's Glioblastoma pipeline report depicts…
Glioblastoma Multiforme Market Insights, Forecast to 2031
"Glioblastoma Multiforme Market 2024,"
The objectives outlined in the report are multifaceted and aimed at offering a comprehensive understanding of the Glioblastoma Multiforme market dynamics. These objectives encompass a meticulous analysis and forecast of the market's dimensions, encompassing both its value and volume aspects. Additionally, the report seeks to discern and delineate the market shares held by major segments within the Glioblastoma Multiforme industry, providing stakeholders with a nuanced perspective on market…
Beyond Bravery - Bill Fitzpatrick's Fight Against Glioblastoma
Bill Fitzpatrick Jr, a retired sales professional from GE, has recently ventured into the world of writing with his debut book. Inspired by his experiences during taking care of his wife, who had Glioblastoma, Bill felt the need to share his journey and provide support to other families navigating similar challenges. In this article, we will dive into Bill's background, his motivation for becoming an author, details about his latest…
Recurrent Glioblastoma Pipeline Outlook Report 2024 (Updated)
DelveInsight's, "Recurrent Glioblastoma Pipeline Insight 2024" report provides comprehensive insights about 50+ companies and 50+ pipeline drugs in Recurrent Glioblastoma pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the Recurrent Glioblastoma Pipeline Report
DelveInsight's Recurrent Glioblastoma…
Revolutionizing Glioblastoma Treatment Strategies: A Deep Dive into the Glioblas …
The Glioblastoma Pipeline Insight 2023 report by DelveInsight offers a thorough global overview of Glioblastoma treatments, including those already in the market, as well as those in different phases of clinical development. Prominent pharmaceutical firms are dedicated to progressing the Glioblastoma pipeline landscape and fostering the potential growth of Glioblastoma therapeutic advancements.
Key Takeaways from the Glioblastoma Pipeline Report
• DelveInsight's Glioblastoma pipeline report depicts a robust space with 195+ active players…